Insider buying · SEC Form 4

Insider Buying — Oct 29, 2026

Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.

8insider buys
$17.9Mbought in total
7companies
2by CEOs, CFOs and other chiefs
CRBGlargest: $6.39M

Every qualifying buy, largest first

StockInsiderValueSharesAvg priceTypeFiled
CRBGCorebridge Financial, Inc.Nippon Life Insurance Co10% Owner$6.39M182,826$34.97AddedOct 28, 2026
Form 4 ↗
182,826 shares at $34.9529 weighted avg (range $34.58–$35.31). Ongoing 10b5-1 plan purchase adopted Aug 7, 2026. Trade date Oct 26.
GOLDGold.com, Inc.Giancarlo Devasini10% Owner$3.93M99,999$39.27AddedOct 28, 2026
Form 4 ↗
Three tranches: 32,675 @ $38.96 (Oct 26), 39,692 @ $39.44 (Oct 27), 27,633 @ $39.39 (Oct 28). Purchased via Tether Global Investments Fund. Post-transaction position: ~3.87M shares.
ACNAccenture PLCJulie Spellman SweetChair and CEO$3.00M12,200$245.99AddedOct 28, 2026
Form 4 ↗
Two tranches on Oct 26: 2,100 @ $245.11 + 10,100 @ $246.17. Open-market purchase. CEO now holds 48,910 shares directly.
BPREBluerock Private Real Estate FundRamin KamfarDirector$2.23M178,677$12.48AddedOct 28, 2026
Form 4 ↗
Two tranches: 109,019 @ $12.477 (Oct 26) + 69,658 @ $12.483 (Oct 27). Purchased via Bluerock Asset Management, LLC (controlled entity). Founder/director accumulation.
TTMITTM Technologies IncAli WajidDirector$902K10,000$90.25AddedOct 28, 2026
Form 4 ↗
Two equal tranches on Oct 28: 5,000 @ $89.857 + 5,000 @ $90.635. Same-day cluster with CEO Roks. Post-transaction: 35,835 shares.
XBITXBiotech Inc.John SimardDirector, 10% Owner$711K368,524$1.93AddedOct 28, 2026
Form 4 ↗
Purchased Oct 26 at $1.93 per share from Thorpe McKenzie (private block transfer, still code P). Post-transaction: 4,191,690 shares.
TTMITTM Technologies IncEdwin RoksPresident and CEO$440K5,000$88.07AddedOct 28, 2026
Form 4 ↗
5,000 shares at $88.07 on Oct 28. Cluster buy — same day as Director Wajid. Post-transaction: 64,483 shares directly.
HBANHuntington Bancshares IncJames D. Rollins IIIDirector$254K14,000$18.12AddedOct 28, 2026
Form 4 ↗
Preferred stock purchases on Oct 26: 4,000 Ser H @ $14.855 + 10,000 Ser I @ $19.43 (wtd avg $19.30–$19.45). HBAN common at $15.70. Director buying preferred tranches, not common.

AIThe day in insider buying

SEC Form 4 Insider Scan — October 29, 2026

Scanned the last 24 hours of EDGAR Form 4 filings (Oct 28–29, 2026). 8 qualifying buys (≥ $250K, transaction type P) totalling ~$17.9M.

Headline Filings

  • CRBG — Nippon Life Insurance Co (10% Owner) bought 182,826 shares ≈ $6.4M at $34.95 avg; now $35.32 (+1.1% since buy). Ongoing 10b5-1 plan accumulation adopted Aug 7, 2026. (filing)
  • GOLD — Giancarlo Devasini / Tether Global Investments Fund (10% Owner) bought 99,999 shares ≈ $3.9M at $39.27 avg (Oct 26–28 across three tranches); now $39.04 (−0.6% since buy). Tether continues to steadily build its Gold.com position. (filing)
  • ACN — Julie Spellman Sweet (Chair & CEO) bought 12,200 shares ≈ $3.0M at $246.02 avg on Oct 26; now $243.40 (−1.1% since buy). Post-earnings open-market buy from Accenture's own chief. (filing)
  • BPRE — Ramin Kamfar (Director) bought 178,677 shares ≈ $2.2M at $12.48 avg (Oct 26–27) via his controlled entity Bluerock Asset Management, LLC; now $12.43 (−0.4% since buy). Continued founder accumulation. (filing)
  • TTMI — Ali Wajid (Director) bought 10,000 shares ≈ $902K at $90.25 avg on Oct 28; now $90.79 (+0.6% since buy). (filing)
  • XBIT — John Simard (Director, 10% Owner) bought 368,524 shares ≈ $711K at $1.93 from Thorpe McKenzie (block purchase) on Oct 26; now $1.99 (+3.1% since buy). (filing)
  • TTMI — Edwin Roks (President & CEO) bought 5,000 shares ≈ $440K at $88.07 on Oct 28; now $90.79 (+3.1% since buy). CEO and Director both buying TTMI on the same day — classic bullish cluster signal. (filing)
  • HBAN — James D. Rollins III (Director) bought 14,000 preferred shares ≈ $254K at $18.12 blended avg (4,000 Ser H @ $14.86 + 10,000 Ser I @ $19.43) on Oct 26; HBAN common now $15.70. Unusual director purchase in preferred tranches. (filing)

Notes

TTMI cluster buy is the most actionable signal today: CEO Edwin Roks AND Director Ali Wajid both purchased on October 28 in the open market — a same-day cluster from two distinct insiders. Roks's buy was at a lower $88.07 avg (possibly early session) vs. Wajid's $90.25 avg. Both are already in the green at $90.79.

ACN CEO purchase: Julie Sweet's $3M open-market buy in Accenture comes after the stock has pulled back from recent highs, and she is slightly underwater at current $243.40 vs. her $246.02 avg cost. CEO conviction buys from mega-cap executives on pullbacks tend to carry signal.

CRBG: Nippon Life's steady drip via a 10b5-1 plan (adopted Aug 7) continues — this is the second consecutive week with a $6M+ filing. Less signal value as discretionary buys, but indicates institutional conviction in Corebridge's valuation at $34–35.

GOLD (Gold.com / Tether): Giancarlo Devasini, CFO of Tether, used Tether's investment vehicle to buy across three days at consistent prices ($38.96–$39.44). The position now sits at 3,870,787 shares. This is a strategic accumulation, not a one-off.

XBIT: John Simard's block purchase was bought "from Thorpe McKenzie" — a private transfer from another institutional holder, not exchange-sourced. Still counts as a P transaction and reflects insider conviction at distressed micro-cap levels.

HBAN preferred is an unusual insider buy: Rollins purchased Series H and Series I perpetual preferred, not common. This type of preferred-share purchase by a director suggests comfort with the bank's credit profile and income yield rather than equity upside.

Most-bought stocks, last 30 days

  • LEN $193M · 1 buyLennar Corporation
  • CRBG $120M · 10 buys, 2 insidersCorebridge Financial, Inc.
  • BORR $51.3M · 8 buysBorr Drilling Ltd
  • GME $50.7M · 4 buys, 2 insidersGameStop Corp.
  • LYCA $37.7M · 1 buyLycia Therapeutics, Inc.
  • ADRX $37.3M · 2 buys, 2 insidersADARx Pharmaceuticals, Inc.
  • GPI $32.6M · 2 buys, 2 insidersGroup 1 Automotive Inc.
  • MSM $29.0M · 1 buyMSC Industrial Direct Co., Inc.
  • BPRE $24.4M · 5 buysBluerock Private Real Estate Fund
  • QVCG $16.7M · 1 buyQVC Group, Inc.
  • AVR $16.6M · 4 buysAnteris Technologies Global Corp.
  • LRN $12.2M · 1 buyStride, Inc.
  • SRRK $12.0M · 1 buyScholar Rock Holding Corp
  • IAM $11.5M · 1 buyIambic Therapeutics, Inc.
  • COUR $11.4M · 1 buyCoursera, Inc.
  • PSUS $9.61M · 1 buyPershing Square USA, Ltd.
  • DOLE $8.55M · 1 buyDole plc
  • GOLD $7.87M · 3 buys, 3 insidersGold.com, Inc.
  • APLD $6.66M · 2 buys, 2 insidersApplied Digital Corp.
  • GPUS $5.00M · 1 buyHyperscale Data, Inc.

All scans

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.